
Massachusetts Lawmakers Prioritize Health Policy
Massachusetts lawmakers made health policy their central focus of the 2025-2026 legislative session.

Massachusetts lawmakers made health policy their central focus of the 2025-2026 legislative session.

Massachusetts lawmakers made health policy their central focus of the 2025-2026 legislative session.
Max Read at Gawker says, There is no such thing as “politicizing” tragedy. James Holmes did not materialize in a movie theater in Aurora this
A thoughtful analysis of the spending clause/coercion issue after NFIB by Kenneth Thomas at CRS was sent along by a helpful TIE reader. This paper
After the Health Care Cases, Red States now have an option out of the Medicaid expansion. But the Court didn’t say exactly what provisions were
Overseas Deployment, Combat Exposure, and Well-Being in the 2010 National Survey of Veterans, by Ryan D. Edwards (The National Bureau of Economic Research) Recent military
(Ed. note: Comments for this post – and all others – will not be approved if they violate the comments policy) My latest piece for
Here’s another recent Twitter essay that several people have requested I turn into a post (prior one here). https://twitter.com/afrakt/status/225959185270075394 https://twitter.com/afrakt/status/225959382603673601 https://twitter.com/afrakt/status/225959594747387904 https://twitter.com/afrakt/status/225959970863198209 https://twitter.com/afrakt/status/225960228041146368 I’m more
I’m obviously sympathetic to publicly funded health research. My career depends on it. So, I can’t in any unbiased way write about the Labor/HHS appropriation
In my new post on the JAMA forum, I game out the new Medicaid expansion option available to states by virtue of the Supreme Court’s
Perhaps you’ve heard about the results of the latest randomized controlled trial (RCT) of radical prostatectomy for treatment of prostate cancer. It’s written up in
Someone sent me this study – “Does Childhood Misfortune Increase Cancer Risk in Adulthood?”: Objective: To address the inconsistent findings on whether childhood misfortune increases
For the past 15 years, a consistent industry argument against low priced generic AIDS drugs in the developing world has been the fear of arbitrage